Gipuzkoa, Spain

Luis Bujanda Fernandez De Pierola


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Luis Bujanda Fernandez De Pierola

Introduction

Luis Bujanda Fernandez De Pierola is a notable inventor based in Gipuzkoa, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of polycystic diseases. His work focuses on the development of innovative compounds that can potentially improve patient outcomes.

Latest Patents

Luis holds a patent for "Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases." This invention relates to compounds derived from ursodeoxycholic acid, which are designed to treat conditions such as autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, and autosomal recessive polycystic kidney disease. The patent highlights the methods for obtaining these compounds and their therapeutic applications.

Career Highlights

Throughout his career, Luis has worked with esteemed institutions, including the University of the Basque Country (Universidad del País Vasco - Euskal Herriko Unibertsitatea) and the General Administration of the Autonomous Community of Euskadi (Administración General de la Comunidad Autónoma de Euskadi). His work in these organizations has contributed to advancements in medical research and innovation.

Collaborations

Luis has collaborated with notable colleagues such as Jesus Maria Banales Asurmendi and Alvaro Santos Laso. These partnerships have fostered a collaborative environment that enhances research and development in the field of polycystic diseases.

Conclusion

Luis Bujanda Fernandez De Pierola is a distinguished inventor whose work in developing ursodeoxycholic acid derivatives has the potential to transform the treatment of polycystic diseases. His contributions to medical research and collaboration with esteemed institutions and colleagues underscore his commitment to innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…